04/02/2020
8:02 AM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2020
8:00 AM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
04/02/2020
7:34 AM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
04/01/2020
3:44 PM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2020
8:05 AM | Progenics Pharmaceuticals (Filer)
| Form DEFM14A
| |
03/16/2020
5:03 AM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2020
7:45 AM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
03/13/2020
7:45 AM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2020
3:15 PM | Das Asha (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2020
3:15 PM | Osorio Benedict (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2020
3:15 PM | Progenics Pharmaceuticals (Issuer)
Wong Vivien (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2020
3:15 PM | Progenics Pharmaceuticals (Issuer)
Tenbarge Bryce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2020
3:15 PM | Fabbio Patrick (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2020
3:20 PM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
02/20/2020
4:18 PM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
02/20/2020
3:59 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
02/20/2020
12:27 PM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2020
12:25 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
02/20/2020
11:25 AM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
02/14/2020
10:25 AM | ARMISTICE CAPITAL, LLC (Filed by)
Progenics Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/14/2020
5:19 AM | FARALLON CAPITAL MANAGEMENT LLC (Filed by)
Progenics Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/13/2020
11:11 AM | Progenics Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/04/2020
11:30 AM | BlackRock Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form SC 13G/A
| |
01/21/2020
4:27 PM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2020
3:33 PM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
01/08/2020
4:19 PM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
01/06/2020
11:23 AM | EAGLE ASSET MANAGEMENT INC (Filed by)
Progenics Pharmaceuticals (Subject)
| Form SC 13G/A
| |
12/23/2019
6:32 AM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2019
3:03 PM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2019
2:16 PM | Maeusli Heinz Christoph (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
2:16 PM | Maeusli Heinz Christoph (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
2:16 PM | Mims David W. (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
2:15 PM | Mims David W. (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
2:15 PM | MacDougall Ann L. (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
2:15 PM | MacDougall Ann L. (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
2:14 PM | Ende Eric J (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
2:14 PM | Ende Eric J (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
2:14 PM | Ber Gerard (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
2:14 PM | Ber Gerard (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2019
3:12 PM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2019
3:51 PM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
12:47 PM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form SC 13D/A
| |
11/12/2019
5:07 AM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2019
4:21 PM | Progenics Pharmaceuticals (Filer)
| Form DEFA14A
| |
11/08/2019
2:52 PM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFAN14A
| |
11/07/2019
4:05 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
11/07/2019
9:08 AM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
11/07/2019
7:31 AM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
11/07/2019
7:15 AM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2019
4:07 PM | Progenics Pharmaceuticals (Filer)
| Form DEFA14A
| |
11/06/2019
4:07 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
11/05/2019
3:45 PM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFAN14A
| |
11/05/2019
8:15 AM | Progenics Pharmaceuticals (Filer)
| Form DEFA14A
| |
11/05/2019
8:12 AM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
11/04/2019
10:10 AM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFAN14A
| |
11/01/2019
4:11 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
11/01/2019
4:09 PM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2019
4:07 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
11/01/2019
8:03 AM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/28/2019
4:10 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/28/2019
9:49 AM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFAN14A
| |
10/24/2019
2:03 PM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFAN14A
| |
10/23/2019
4:12 PM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFAN14A
| |
10/23/2019
3:29 PM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2019
3:28 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/23/2019
3:22 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/23/2019
8:01 AM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/22/2019
10:32 AM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFAN14A
| |
10/21/2019
6:32 PM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2019
6:30 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/21/2019
4:05 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/21/2019
11:06 AM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFAN14A
| |
10/18/2019
4:04 PM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2019
11:46 AM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFAN14A
| |
10/11/2019
3:03 PM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFRN14A
| |
10/09/2019
7:27 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/08/2019
3:25 PM | Progenics Pharmaceuticals (Subject)
| Form DEFC14A
| |
10/08/2019
10:14 AM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFAN14A
| |
10/04/2019
4:21 PM | Progenics Pharmaceuticals (Filer)
| Form PRER14A
| |
10/04/2019
4:07 PM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/04/2019
4:05 PM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/02/2019
4:22 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/02/2019
4:18 PM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/02/2019
4:17 PM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/02/2019
3:45 PM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/02/2019
1:36 PM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFAN14A
| |
10/02/2019
8:24 AM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/02/2019
6:42 AM | Progenics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2019
6:40 AM | Progenics Pharmaceuticals (Subject)
| Form 425
| |
10/02/2019
6:27 AM | Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form 425
| |
09/30/2019
4:23 PM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form PRRN14A
| |
09/27/2019
4:23 PM | MacDougall Ann L. (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/27/2019
4:21 PM | Mims David W. (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/27/2019
4:18 PM | Maeusli Heinz Christoph (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/27/2019
4:16 PM | Ende Eric J (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/27/2019
4:13 PM | Ber Gerard (Reporting)
Progenics Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/25/2019
9:21 AM | Progenics Pharmaceuticals (Subject)
| Form PREC14A
| |
09/19/2019
4:23 PM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form SC 13D/A
| |
09/18/2019
2:30 PM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form DFAN14A
| |
09/18/2019
7:34 AM | Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
| Form PREC14A
| |
